What Genetics is Telling Us About Substance Use Disorders - A Free Webinar from the Brain & Behavior Research Foundation
29 juin 2023 14h55 HE
|
Brain & Behavior Research Foundation
New York, June 29, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “What Genetics is Telling Us About Substance Use Disorders” on Tuesday,...
AI-Based Health Screening Company iHealthScreen Announces Q&A Webinar
27 juin 2023 15h16 HE
|
iHealthScreen Inc.
RICHMOND HILL, N.Y., June 27, 2023 (GLOBE NEWSWIRE) -- via IBN -- AI-based health screening company iHealthScreen today announces it will host an exclusive Q&A webinar on July 11 at 9 a.m. PDT....
Join the AtomBeam Webinar and Discover the Power of Advanced Data Compression Technology
06 juin 2023 14h52 HE
|
AtomBeam
MORAGA, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- via IBN -- AtomBeam Technologies, the leader in IoT data reduction with its Compaction software, is excited to invite investors to our highly...
Tiziana Life Sciences Announces Reduction in Microglial Activation in a Total of 5 Out of 6 Intranasal Foralumab Expanded Access Patients with Non-Active Secondary Progressive Multiple Sclerosis
05 juin 2023 10h00 HE
|
Tiziana Life Sciences Ltd.
Results confirm positive signal previously reported in the first two Expanded Access patients who both subsequently demonstrated clinical improvementsPhase 2a trial in na-SPMS on track to begin in Q3...
CHAR Technologies To Be Featured on Radius Research's Pitch, Deep Dive and Q&A Webinar May 31st
30 mai 2023 08h30 HE
|
CHAR Technologies Ltd.
TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- CHAR Technologies Ltd. (“CHAR” or the “Company”) (TSXV:YES), is pleased to invite investors and other interested parties to attend an upcoming interview...
Tiziana Life Sciences to Host KOL Webinar on Foralumab in Non-Active Secondary Progressive Multiple Sclerosis (SPMS)
25 mai 2023 07h00 HE
|
Tiziana Life Sciences Ltd.
NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies via...
AS Tallinna Vesi ja AS Utilitas Tallinn sõlmisid lepingu hoonestusõiguse seadmiseks
17 mai 2023 05h06 HE
|
Tallinna Vesi
AS Tallinna Vesi ja AS Utilitas Tallinn on kokku leppinud hoonestusõiguse seadmises AS-ile Tallinna Vesi kuuluvale Paljassaare põik 14 asuvale kinnistule reoveesoojuspumbajaama ja seda teenindavate...
AS Tallinna Vesi and AS Utilitas Tallinn concluded an agreement to establish a right of superficies
17 mai 2023 05h06 HE
|
Tallinna Vesi
AS Tallinna Vesi and AS Utilitas Tallinn have agreed to establish a right of superficies for the construction and operation of a wastewater heat pump plant and the buildings serving it on the...
AS Tallinna Vesi allkirjastas laenulepingu summas 91 miljonit eurot
16 mai 2023 03h50 HE
|
Tallinna Vesi
AS Tallinna Vesi ja AS SEB Pank koos pankade Swedbank AS ja OP Corporate Bank plc Eesti filiaal sõlmisid sündikaatlaenu lepingu kogusummas 91 miljonit eurot. Laenulepingu tähtaeg on 15.05.2028 ning...
AS Tallinna Vesi signed a loan agreement for a total amount of EUR 91 million
16 mai 2023 03h50 HE
|
Tallinna Vesi
AS Tallinna Vesi and AS SEB Pank, together with Swedbank AS and OP Corporate Bank plc Estonian branch, signed a syndicated loan agreement for a total amount of EUR 91 million. The maturity of the loan...